These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 310279)
21. Beta-lactamase inhibitors from laboratory to clinic. Bush K Clin Microbiol Rev; 1988 Jan; 1(1):109-23. PubMed ID: 3060240 [TBL] [Abstract][Full Text] [Related]
22. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli. Jacobs MR; Aronoff SC; Johenning S; Shlaes DM; Yamabe S Antimicrob Agents Chemother; 1986 Jun; 29(6):980-5. PubMed ID: 3015017 [TBL] [Abstract][Full Text] [Related]
23. An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor. Greenwood D; O'Grady F; Baker P J Antimicrob Chemother; 1979 Sep; 5(5):539-47. PubMed ID: 387706 [TBL] [Abstract][Full Text] [Related]
24. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli. Paisley JW; Washington JA Antimicrob Agents Chemother; 1978 Aug; 14(2):224-7. PubMed ID: 308792 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis. Piot P; Van Dyck E Antimicrob Agents Chemother; 1982 Jan; 21(1):166-7. PubMed ID: 6805422 [TBL] [Abstract][Full Text] [Related]
26. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase. Cherubin CE; Eng RH; Smith SM; Tan EN J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and beta-lactamase inhibitory activities of some clavulanic acid analogues. Mak CP; Prasad K; Turnowsky F J Antibiot (Tokyo); 1983 Apr; 36(4):398-406. PubMed ID: 6602120 [TBL] [Abstract][Full Text] [Related]
28. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam. Chin NX; McElrath MJ; Neu HC Chemotherapy; 1988; 34(4):318-25. PubMed ID: 2850139 [TBL] [Abstract][Full Text] [Related]
29. HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria. Neu HC; Aswapokee N; Aswapokee P; Fu KP Antimicrob Agents Chemother; 1979 Feb; 15(2):273-81. PubMed ID: 426518 [TBL] [Abstract][Full Text] [Related]
30. Antibacterial activity of ticarcillin in the presence of clavulanate potassium. Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080 [TBL] [Abstract][Full Text] [Related]
31. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria. Aldridge KE; Sanders CV; Marier RL J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724 [TBL] [Abstract][Full Text] [Related]
32. Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129. Campos M; Alarcón MA; González H; Sánchez R Microbios; 1993; 76(308):171-9. PubMed ID: 8302198 [TBL] [Abstract][Full Text] [Related]
33. Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi. Girouard YC; Maclean IW; Ronald AR; Albritton WL Antimicrob Agents Chemother; 1981 Jul; 20(1):144-5. PubMed ID: 6974538 [TBL] [Abstract][Full Text] [Related]
34. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene. Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320 [TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate. Fass RJ; Prior RB Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904 [TBL] [Abstract][Full Text] [Related]
36. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam. Piddock LJ; Jin YF; Turner HL J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105 [TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Coleman K; Griffin DR; Page JW; Upshon PA Antimicrob Agents Chemother; 1989 Sep; 33(9):1580-7. PubMed ID: 2817854 [TBL] [Abstract][Full Text] [Related]
38. Inconsistency of synergy between the beta-lactamase inhibitor CP-45,899 and beta-lactam antibiotics against multiply drug-resistant Enterobacteriaceae and pseudomonas species. Fass RJ Antimicrob Agents Chemother; 1981 Feb; 19(2):361-3. PubMed ID: 6289732 [TBL] [Abstract][Full Text] [Related]
39. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'. Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439 [TBL] [Abstract][Full Text] [Related]
40. In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics. Melchior NH; Keiding J J Antimicrob Chemother; 1991 Jan; 27(1):29-40. PubMed ID: 1646779 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]